JP2017530943A5 - - Google Patents

Download PDF

Info

Publication number
JP2017530943A5
JP2017530943A5 JP2017506931A JP2017506931A JP2017530943A5 JP 2017530943 A5 JP2017530943 A5 JP 2017530943A5 JP 2017506931 A JP2017506931 A JP 2017506931A JP 2017506931 A JP2017506931 A JP 2017506931A JP 2017530943 A5 JP2017530943 A5 JP 2017530943A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
acceptable salt
compound
hydrocarbyl
hydride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017506931A
Other languages
English (en)
Japanese (ja)
Other versions
JP6353159B2 (ja
JP2017530943A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/043830 external-priority patent/WO2016022700A2/en
Publication of JP2017530943A publication Critical patent/JP2017530943A/ja
Publication of JP2017530943A5 publication Critical patent/JP2017530943A5/ja
Application granted granted Critical
Publication of JP6353159B2 publication Critical patent/JP6353159B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017506931A 2014-08-06 2015-08-05 Tlr非依存性低分子アジュバント Active JP6353159B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462033918P 2014-08-06 2014-08-06
US62/033,918 2014-08-06
PCT/US2015/043830 WO2016022700A2 (en) 2014-08-06 2015-08-05 Tlr-independent small molecule adjuvants

Publications (3)

Publication Number Publication Date
JP2017530943A JP2017530943A (ja) 2017-10-19
JP2017530943A5 true JP2017530943A5 (https=) 2017-12-14
JP6353159B2 JP6353159B2 (ja) 2018-07-04

Family

ID=55264758

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017506931A Active JP6353159B2 (ja) 2014-08-06 2015-08-05 Tlr非依存性低分子アジュバント

Country Status (7)

Country Link
US (1) US9918959B2 (https=)
EP (1) EP3177601B1 (https=)
JP (1) JP6353159B2 (https=)
AU (1) AU2015301100B2 (https=)
CA (1) CA2957372C (https=)
ES (1) ES2944541T3 (https=)
WO (1) WO2016022700A2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102522730B1 (ko) * 2016-06-29 2023-04-19 더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 디프로보심: 새로운 강력한 부류의 tlr 작용제
CN113164445A (zh) * 2018-08-02 2021-07-23 得克萨斯系统大学评议会 Tlr1/2激动剂地普罗考姆的佐剂作用协同增效检查点抑制性抗体以消除疾病

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2577514T3 (es) * 2005-08-22 2016-07-15 The Regents Of The University Of California Antagonistas de TLR
ES2552471T3 (es) 2007-02-07 2015-11-30 The Regents Of The University Of California Conjugados de agonistas de TLR sintéticos y usos de los mismos
WO2008112939A2 (en) * 2007-03-13 2008-09-18 Board Of Regents, The University Of Texas System Composition and method for making oligo-benzamide compounds
PT2268618E (pt) * 2008-03-03 2015-10-12 Novartis Ag Compostos e composições moduladores da actividade tlr

Similar Documents

Publication Publication Date Title
JP2016515561A5 (https=)
JP2020534355A5 (https=)
JP2011518833A5 (https=)
JP2013032389A5 (https=)
JP2010501534A5 (https=)
JP2016503793A5 (https=)
JP2015078230A5 (https=)
JP2014500861A5 (https=)
JP2017513917A5 (https=)
JP2017537066A5 (https=)
JP2011105738A5 (https=)
JP2017506666A5 (https=)
JP2013507423A5 (https=)
JP2018531941A5 (https=)
JP2017533930A5 (https=)
JP2018521056A5 (https=)
JP2013542261A5 (https=)
JP2015512946A5 (https=)
JP2012532883A5 (https=)
JP2011527299A5 (https=)
JP2020097577A5 (https=)
JP2019535723A5 (https=)
JP2016505614A5 (https=)
JP2020500916A5 (https=)
JP2018538273A5 (https=)